Transplantation Osteoporosis

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 279-285

  Ebeling, Peter R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889287883     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch61     Document Type: Chapter

References (72)

1. Cohen A, Sambrook P, Shane E 2004 Management of bone loss after organ transplantation. J Bone Miner Res 19:1919-1932.
2. Cohen A, Shane E 2003 Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 14:617-630.
3. Gal-Moscovici A, Sprague SM 2007 Osteoporosis and chronic kidney disease. Semin Dial 20:423-130.
4. Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heck-bert SR, Wong CS, Ball A, Weiss NS 2000 Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200-2205.
5. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C 2000 Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396-399.
6. Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C 2002 Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014-3018.
7. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Ad-desso V, McMahon DJ 1997 Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. Am J Med 103:197-207.
8. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Ordi J, Rimola A, Rodes J, Munoz-Gomez J 2001 Bone disease after liver transplantation: A long-term prospective study of bone mass changes, hormonal status and histomorpho-metric characteristics. Osteoporos Int 12:484-492.
9. Millonig G, Graziadei IW, Eichler D, Pfeiffer KP, Finkenstedt G, Muehllechner P, Koenigsrainer A, Margreiter R, Vogel W 2005 Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: A prospective single-center study. Liver Transpl 11:960-966.
10. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE 2001 High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 69:321-326.
11. Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW, Schmid C 2002 Osteoporosis before lung transplantation: Association with low body mass index, but not with underlying disease. Am J Transplant 2:167-172.
12. Keilholz U, Max R, Scheibenbogen C, Wuster C, Korbling M, Haas R 1997 Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer 79:1617-1622.
13. Tauchmanova L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A 2002 High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 95:1076-1084.
14. Valimaki M, Kinnunen K, Volin L, Tahtela R, Loyttniemi E, Laitinen K, Makela P, Keto P, Ruutu T 1999 A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 23:355-361.
15. Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MJ 2005 Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 90:3877-3885.
16. Schulte C, Bcelen D, Schaefer U, Mann K 2000 Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospectiv estudy. Osteoporos Int 11:344-353.
17. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000.
18. Epstein S 1996 Post-transplantation bone disease: The role of immunosuppressive agents on the skeleton. J Bone Miner Res 11:1-7.
19. Ponticelli C, Aroldi A 2001 Osteoporosis after organ transplantation. Lancet 357:1623.
20. Mclntyre HD, Menzies B, Rigby R, Perry-Keene DA, Hawley CM, Hardie IR 1995 Long-term bone loss after renal transplantation: Comparison of immunosuppressive regimens. Clin Transplant 9:20-24.
21. Stempfle HU, Werner C, Echtler S, Assum T, Meiser B, Anger-mann CE, Theisen K, Gartner R 1998 Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. Transplant Proc 30:1132-1133.
22. Park KM, Hay JE, Lee SG, Lee YJ, Wiesner RH, Porayko MK, Krom RA 1996 Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. Transplant Proc 28:1738-1740.
23. Goffin E, Devogelaer JP, Depresseux G, Squifflet JP, Pirson Y 2001 Osteoporosis after organ transplantation. Lancet 357:1623.
24. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J 2001 Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83-86.
25. Singha UK, Jiang Y, Yu S, Luo M, Lu Y, Zhang J, Xiao G 2008 Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 103:434-436.
26. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarries LD 1991 Rapid loss of vertebral bone density after renal transplantation. N Engl J Med 325:544-550.
27. Monier-Faugere M, Mawad H, Qi Q, Friedler R, Malluche HH 2000 High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11:1093-1099.
28. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM 1999 Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456-463.
29. Sprague SM, Josephson MA 2004 Bone disease after kidney transplantation. Semin Nephrol 24:82-90.
30. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramovvicz D 2005 A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79:108-115.
31. Grotz W, Nagel C, Poeschel D, Cybulla M, Petersen KG, Uhl M, Strey C, Kirste G, Olschewski M, Reichelt A, Rump LC 2001 Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 12:1530-1537.
32. Kovac D, Lindic J, Kandus A, Bren AF 2001 Prevention of bone loss in kidney graft recipients. Transplant Proc 33:1144-1145.
33. Giannini S, Dangel A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Cre-paldi G 2001 Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111-2117.
34. Torres A, Garcia S, Gomez A, Gonzalez A, Barrios Y, Conception MT, Hernandez D, Garcia JJ, Checa MD, Lorenzo V, Salido E 2004 Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65:705-712.
35. Miller PD 2005 Treatment of osteoporosis in chronic kidney disease and end-stage renal disease. Curr Osteoporos Rep 3:5-12.
36. Schwarz CL, Mitterbauer CL, Heinze G, Woloszczuk W, Haas M, Oberbauer R 2004 Nonsustained effect of short-term bisphospho-nate therapv on bone turnover three years after renal transplantation. Kidney Int 65:304-309.
37. Palmer SC, McGregor DO, Strippoli GFM 2007 Interventions fo preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 18:CD005015.
38. Chiu MY, Sprague SM, Bruce DS, Woodle ES, Thistlethwaite JR Jr, Josephson MA 1998 Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 9:677-683.
39. Smets YFC, De Fijter JW, Ringers J, Lemkes HHPJ, Hamdy NAT 2004 Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidnev transplantation. Kidney Int 66:2070-2076.
40. Shane E, Papadopoulos A, Staron RB, Addesso V, Donovan D, McGregor C, Schulman LL 1999 Bone loss and fracture after lung transplantation. Transplantation 68:220-227.
41. Aris RM, Lester GE, Renner JB, Winders A, Denene Blackwood A, Lark RK, Ontjes DA 2000 Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 162:941-946.
42. Trombetti A, Gerbase MW, Spiliopoulos A, Slosman DO, Nicod LP, Rizzoli R 2000 Bone mineral density in lung-transplant recipients before and after graft: Prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. J Heart Lung Transplant 19:736-743.
43. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel M, Kuiper J, Mancini D, Addesso V, Michler RE, Factor-Litvak P 1996 Fracture after cardiac transplantation: A prospective longitudinal study. J Clin Endocrinol Metab 81:1740-1746.
44. Leidig-Bruckner G, Hosch S, Dodidou P, Ritchel D, Conradt C, Klose C, Otto G, Lange R, Theilmann L, Zimmerman R, Pritsch M, Zeigler R 2001 Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow-up study. Lancet 357:342-347.
45. Sambrook P, Henderson NK, Keogh A, MacDonald P, Glanville A, Spratt P, Bergin P, Ebeling P, Eisman J 2000 Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15:1818-1824.
46. Henderson K, Eisman J, Keogh A, MacDonald P, Glanville A, Spratt P, Sambrook P 2001 Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 16:565-571.
47. Stempfle HU, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uberfuhr P, Angermann CE, Theisen K, Gartner R 1999 Prevention of osteoporosis after cardiac transplantation: A prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 68:523-530.
48. Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C 2000 Prevention of osteoporosis in heart transplant recipients: A comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 67:116-121.
49. Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767-776.
50. Cohen A, Addesso V, McMahon DJ, Staron RB, Namerow P, Maybaum S, Mancini D, Shane E 2006 Discontinuing antiresorp-tive therapy one year after cardiac transplantation: Effect on bone density and bone turnover. Transplantation 81:686-691.
51. Mitchell MJ, Baz MA, Fulton MN, Lisor CF, Braith R 2003 Resistance training prevents vertebral osteoporosis in lung transplant recipients. Transplantation 76:557-562.
52. Braith RW, Magyari PM, Fulton MN, Lisor CF, Vogel SE, Hill JA, Aranda JM Jr 2006 Comparison of calcitonin versus calcitonin and resistance exercise as prophylaxis for osteoporosis in heart transplant recipients. Transplantation 81:1191-1195.
53. Ninkovic M, Skingle SJ, Bearcroft PW, Bishop N, Alexander CJ, Compston JE 2000 Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931-935.
54. Hommann M, Abendroth K, Lehmann G, Patzer N, Kornberg A, Voigt R, Seifert S, Hein G, Scheele J 2002 Effect of transplantation on bone: Osteoporosis after liver and multivisceral transplantation. Transplant Proc 34:2296-2298.
55. Crawford BAL, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, McCaughan GW 2006 Zoledronic acid prevents bone loss after liver transplantation: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:239-248.
56. Karasu Z, Kilic M, Tokat Y 2006 The prevention of bone fractures after liver transplantation: Experience with alendronate treatment. Transplant Proc 38:1448-1452.
57. Awan KS, Wagner JM, Martin D, Medich DL, Perera S, Abu Elmagd K, Greenspan SL 2007 Bone loss following small bowel transplantation. J Bone Miner Res 22:S356.
58. Banfi A, Podesta M, Fazzuoli L, Sertoli MR, Venturini M, Santini G, Cancedda R, Quarto R 2001 High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: A mechanism for post-bone marrow transplantation osteopenia. Cancer 92:2419-2428.
59. Lee WY, Cho SW, Oh ES, Oh KW, Lee JM, Yoon KH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC 2002 The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 87:329-335.
60. Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MJ 2005 Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 90:3877-3885.
61. Ebeling P. Thomas D, Erbas B, Hopper L, Szer J, Grigg A 1999 Mechanism of bone loss following allogeneic and autologous he-matopoeitic stem cell transplantation. J Bone Miner Res 14:342-350.
62. Ebeling PR 2005 Bone disease after bone marrow transplantation. In: Compston J, Shane E (eds.) Bone Disease of Organ Transplantation. Elsevier, Academic Press, San Diego, CA, USA, pp. 339-352.
63. Lee WY, Kang MI, Baek KH, Oh ES, Oh KW, Lee KW, Kim SW, Kim CC 2002 The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study. J Korean Med Sci 17:749-754.
64. Gandhi MK, Lekamwasam S, Inman I, Kaptoge S, Sizer L, Love S, Bearcroft PW, Milligan TP, Price CP, Marcus RE, Compston JE 2003 Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: Long-term follow-up of a prospective study. Br J Haematol 121:462-468.
65. Ebeling PR 2005 Is defective osteoblast function responsible for bone loss from the proximal femur despite pamidronate therapy? J Clin Endocrinol Metab 90:4414-4416.
66. Tauchmanova L, De Rosa G, Serio B, Fazioli F, Mainolfi C, Lom-bardi G, Colao A, Salvatore M, Rotoli B, Selleri C 2003 Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: A single center experience and a review. Cancer 97:2453-2461.
67. Tauchmanova L, Selleri C, Esposito M, Di Somma C, Orio F Jr, Bifulco G. Palomba S, Lombardi G, Rotoli B, Colao A 2003 Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int 14:1013-1019.
68. Tauchmanova L, Ricci P, Serio B, Lombardi G, Colao A, Rotoli B, Selleri C 2005 Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation. J Clin Endocrinol Metab 90:627-634.
69. Grigg AP, Shuttleworth P, Reynolds J, Schwarer AP, Szer J, Brad-stock K 2006 Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 91:3835-3843.
70. D'Souza AB, Grigg AP. Szer J, Ebeling PR 2006 Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. Intern Med J. 36:600-603.
71. Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME 2006 Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361-1372.
72. Chan GK. Miao D, Deckelbaum R, Bolivar I, Karaplis A, Goltz-man D 2003 Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T mesenchymal cells. Endocrinology 144:5511-5520.